To establish the clinical relevance of these findings, TRIM4 and SET protein levels were next assessed in 116 primary tumor tissue samples collected from ER‐α positive breast cancer patients undergoing adjuvant TAM treatment at Qilu Hospital. This evidence concerns the gene TRIM4 and neoplasm.